DE2608226A1 - AGENTS WITH PHYSIOLOGICAL COOLING EFFECT - Google Patents
AGENTS WITH PHYSIOLOGICAL COOLING EFFECTInfo
- Publication number
- DE2608226A1 DE2608226A1 DE19762608226 DE2608226A DE2608226A1 DE 2608226 A1 DE2608226 A1 DE 2608226A1 DE 19762608226 DE19762608226 DE 19762608226 DE 2608226 A DE2608226 A DE 2608226A DE 2608226 A1 DE2608226 A1 DE 2608226A1
- Authority
- DE
- Germany
- Prior art keywords
- cooling effect
- carbon atoms
- acid
- esters
- menthol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
- C11B9/00—Essential oils; Perfumes
- C11B9/0026—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring
- C11B9/0034—Essential oils; Perfumes compounds containing an alicyclic ring not condensed with another ring the ring containing six carbon atoms
Description
HAARMANN & REIMERHAARMANN & REIMER
■l'■ l '
B/Kp/PfB / Kp / Pf
Die Erfindung betrifft Mittel mit physiologischer Kühlwirkung auf Haut und Schleimhäute des Körpers.The invention relates to agents with a physiological cooling effect on the skin and mucous membranes of the body.
Menthol, der Hauptinhaltstoff der Pfefferminzöle zeichnet sich durch seine hervorragende Kühlwirkung auf Haut und Schleimhäute des Körpers aus. Seine Kühlwirkung beruht dabei nicht au:? einer latenten Verdampfungswärme, sondern entsteht durch direkte Einwirkung der Verbindung auf die Nervenenden von Kälterezeptoren. Die Geruchs- und Geschmackseigenschaften von Menthol schränken jedoch seine Verwendung ein bzw. machen sie sogar in einigen Fällen unmöglich. Der Geruch nach Pfefferminz ist für verschiedene Anwendungsgebiete zu spezifisch und zu scharf und tränen- und sohleimhautreizend. Für andere Anwendungsgebiete ist der Geschmack zu scharf und bitter. Nachteilig wirkt sich oftauch die große Flüchtigkeit von Menthol aus. Menthol, the main ingredient in peppermint oils, is characterized by its excellent cooling effect on the skin and mucous membranes of the body. Its cooling effect is not based on:? a latent heat of vaporization, but arises from the direct action of the compound on the nerve endings of cold receptors. However, the smell and taste properties of menthol limit its use or, in some cases, even make it impossible. The smell of peppermint is too specific and too pungent for various areas of application and irritates tears and the mucous membrane of the sole. For other applications, the taste too sharp and bitter is. The great volatility of menthol often has a disadvantageous effect.
Es hat daher nicht an Versuchen gefehlt, Stoffe zu findan, die den positiven Effekt der Kühlwirkung besitzen, ohne die oben geschilderten Nachteile des Menthols aufzuweisen. So werden z.B. in der DT-OS 2 202 535 p-Menthan-3-carboxamid und Ester der p-Menthan-3-carbonsäure, in der DT-OS 2 205 255 N-substituierte p-Methan-3-carboxamide, in der DT-OS 2 317 538 substituierte Amide, in der DT-OS 2 334 985 cyclische und acyclische SulfoxideThere has therefore been no lack of attempts to find substances which have the positive effect of cooling without having the disadvantages of menthol described above. Thus, for example, in DT-OS-p-menthane-3-carboxamide 2,202,535 and esters of p-menthane-3-carboxylic acid, in the DT-OS 2205255 N-substituted p-methane-3-carboxamides in which DT-OS 2,317,538 substituted amides, in DT-OS 2,334,985 cyclic and acyclic sulfoxides
HR 62 - 1 -HR 62 - 1 -
709836/0088709836/0088
und Sulfone und in der DT-OS 2 345 156 substituierte Phosphinoxide vorgeschlagen.and sulfones and phosphine oxides substituted in DT-OS 2,345,156 suggested.
Die Verbindungen, die dem gesetzten Ziel, eine Kühlwirkung aufzuweisen und dabei geruch- und geschmacklos zu sein, teilweise sehr nahekommen, haben jedoch den Nachteil, daß sie weder natürlich vorkommende Stoffe sind, noch vom menschlischen Organismus zu natürlich vorkommenden Stoffen abgebaut werden können. Sie sind daher physiologisch und lebensmittelrechtlich bedenklich. Zudem sind sie teilweise sehr teuer, da sie nur in vielstufigen Verfahren herstellbar sind.The compounds that meet the set goal of having a cooling effect while being odorless and tasteless, in part come very close, however, have the disadvantage that they are neither naturally occurring substances nor of human nature Organism can be broken down into naturally occurring substances. They are therefore physiological and food law dubious. In addition, they are sometimes very expensive because they can only be produced in multi-stage processes.
Die bisher vorgeschlagenen Derivate des Menthols, die entweder natürlich vorkommen oder vom Organismus zu natürlich vorkommenden Stoffen abgebaut werden, erfüllen die an sie gestellten Anforderungen nur unvollkommen. So weist das in der DT-OS 2 022 364 vorgeschlagene 1-Menthyläthylcarbonat einen orangenartigen Geruch auf, der in der DT-OS 2 433 165 vorgeschlagenen N-Acetylglycin-menthylester sowie die in der DT-OS 2 339 661 vorgeschlagenen Mentholester von heterocyclischen Carbonsäuren sind bitter und die in der US-PS 3 830 vorgeschlagenen Menthylketoester sind z. T. anhaltend bitter und weisen nicht die gewünschte Kühlwirkung auf.The derivatives of menthol proposed so far, which either occur naturally or are broken down by the organism to form naturally occurring substances, only incompletely meet the requirements placed on them. For example, the 1-menthyl ethyl carbonate proposed in DT-OS 2 022 364 has an orange-like odor, the N-acetylglycine menthyl ester proposed in DT-OS 2 433 165 and the menthol esters of heterocyclic carboxylic acids proposed in DT-OS 2 339 661 are bitter and the menthyl ketoesters proposed in U.S. Patent 3,830 are e.g. T. persistently bitter and do not have the desired cooling effect.
Es wurde nun überraschend gefunden, daß Ester aus Menthol und natürlich vorkommenden Hydroxycarbonsäuren mit 2 bis 6 C-Atomen, die gegebenenfalls an der Hydroxygruppe der Carbonsäure verestert sind, geruch- und geschmacklos sind und eine ausgezeichnete, insbesondere langanhaltende Kühlwirkung aufweisen. It has now been found, surprisingly, that esters of menthol and naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms, which are optionally esterified on the hydroxyl group of the carboxylic acid, are odorless and tasteless and have an excellent, especially long-lasting cooling effect.
Die Erfindung betrifft daher Mittel mit physiologischer Kühlwirkung auf Haut und Schleimhäute des Körpers, die dadurchThe invention therefore relates to agents with a physiological cooling effect on the skin and mucous membranes of the body that this causes
HR 62 - 2 -HR 62 - 2 -
709836/0088709836/0088
gekennzeichnet sind, daß sie Ester aus Menthol und natürlich vorkommenden Hydroxycarbonsäuren mit 2 bis 6 C-Atomen, die gegebenenfalls ihrerseits an der Hydroxygruppe mit 1 bis 4 C-Atome aufweisenden Carbonsäuren verestert sind, enthalten.are characterized in that they are esters of menthol and naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms, the are optionally in turn esterified on the hydroxyl group with 1 to 4 carbon atoms containing carboxylic acids.
Als natürlich vorkommende Hydroxycarbonsäuren mit 2 bis 6 C-Atomen seien beispielsweise genannt: Glycolsäure, ß-Hydroxybuttersäure, CC- Hydr oxy is ovaler iansäure, (t-Hydroxy-ct-methylvaleriansäure, (t-Hydroxy-JT-methylvaleriansäure, CG-Hydroxycapronsäure und ß-Hydroxycapronsäure, insbesondere aber Milchsäure.Examples of naturally occurring hydroxycarboxylic acids with 2 to 6 carbon atoms are: glycolic acid, ß-hydroxybutyric acid, CC- Hydroxy is ovalic acid, (t-Hydroxy-ct-methylvaleric acid, (t-Hydroxy-JT-methylvaleric acid, CG-hydroxycaproic acid and ß-hydroxycaproic acid, but especially lactic acid.
Als 1 bis 4-C-Atome aufweisende Carbonsäuren, mit denen die Hydroxygruppe der Hydroxycarbonsäuren verestert sein kann, seien vor allem Ameisensäure, Essigsäure und Propionsäure genannt.As carboxylic acids having 1 to 4 carbon atoms, with which the hydroxyl group of the hydroxycarboxylic acids can be esterified, formic acid, acetic acid and propionic acid are especially mentioned.
Die erfindungsgemäß zu verwendenden Ester sind nur zum Teil neu. Von den beschriebenen Estern war jedoch unbekannt, daß sie eine physiologische Kühlwirkung auf Haut und Schleimhäute des Körpers ausüben. Die Ester können nach herkömmlichen Verfahren hergestellt werden, beispielsweise durch sauer katalysierte Veresterung von Menthol mit Hydroxycarbonsäuren oder durch Reduktion von Ketocarbonsäurementhylestern.Die Ketocarbonsäurementhylester sind ihrerseits z.B. durch Umesterung von Ketocarbonsäurealkylestern mit Menthol erhältlich. Die Veresterung der Hydroxygruppe der Hydroxycarbonsäure mit den 1 bis 4 C-Atome aufweisenden Carbonsäuren wird zweckmäßigerweise als letzte Stufe durchgeführt.The esters to be used according to the invention are only partly new. Of the esters described, however, it was unknown that they were one have a physiological cooling effect on the skin and mucous membranes of the body. The esters can be prepared by conventional methods , for example by acid-catalyzed esterification of menthol with hydroxycarboxylic acids or by reduction of Keto-Mementhyl Ester are in turn obtainable e.g. by transesterification of ketocarboxylic acid alkyl esters with menthol. The esterification the hydroxyl group of the hydroxycarboxylic acid with the 1 to 4 carbon atoms having carboxylic acids is expediently as last stage carried out.
Die erfindungsgemäß zu verwendenden Ester weisen asymmetrische C-Atome auf; bei ihnen kann daher optische Isomerie auftreten. Je nach Ausgangsmaterial und angewendeten Herstellungsmethoden können sie als Gemische der optischen Isomeren oder als reine Isomere vorliegen. Die Kühlwirkung der Isomeren kann unterschiedlich sein, so daß das eine oder andere Isomere bevorzugt sein kann.The esters to be used according to the invention have asymmetric carbon atoms; optical isomerism can therefore occur in them. Depending on the starting material and the manufacturing methods used, they can be used as mixtures of the optical isomers or as pure Isomers exist. The cooling effect of the isomers can be different, so that one or the other isomer is preferred can be.
HR 62 - 3 -HR 62 - 3 -
709836/0088709836/0088
Die erfindungsgemaßen Kühlmittel können überall da angewendet werden, wo eine physiologische Kühlwirkung erwünscht ist. Zusammensetzungen, in denen solche Kühlmittel gern verwendet werden sind beispielsweise Genußmittel wie Kaugummi, Kautabak, Zigaretten, Getränke, Eis, Konfekt usw., pharmazeutische Präparate, Körperpflegemittel oder kosmetische Präparate, wie Zahnreinigungsmittel, Mundwasser, Gurgelpräparate, Parfüms, Puder, Lotionen, Salben, OeIe, Cremes, Rasierwässer. Shampoos usw.The coolants according to the invention can be used anywhere where a physiological cooling effect is desired. Compositions in which such coolants like to be used Examples of luxury items such as chewing gum, chewing tobacco, cigarettes, beverages, ice cream, confectionery, etc., pharmaceutical preparations, personal care products or cosmetic preparations such as dentifrices, mouthwashes, gargle preparations, perfumes, powders, lotions, Ointments, oils, creams, aftershave lotions. Shampoos etc.
Die Endprodukte enthalten die erfindungsgemäß zu verwendenden Ester in einer Menge, die ausreicht, um die Kälterezeptoren zu stimulieren und das erwünschte Kälteempfinden hervorzurufen. In der Regel kommen 0,1 bis 5 Gewichtsprozent bezogen auf das Gewicht der Gesamtzusammensetzung zur Anwendung. Neben der Kühlwirkung weisen die erfindungsgemäßen Ester, insbesondere das Menthyllactat, eine Enhancerwirkung, d.h. eine geschmackverstärkende Wirkung für andere Geschmackstoffe auf. Beispielsweise gestattet der Zusatz einer auch unterhalb des Schwellenwertes für eine physiologische Kühlwirkung liegenden Menge der erfindungsgemäß zu verwendenden Ester die z.B. Kaugummis oder Dentominten als Geschmackstoffe einverleibte Menge an Pfefferminzöl, Krauseminzöl, oder anderen Geschmackstoffen herabzusetzen,ohne daß eine Abweichung des GeBchmackes eintritt.The end products contain the esters to be used according to the invention in an amount sufficient to protect the cold receptors to stimulate and induce the desired sensation of cold. As a rule, 0.1 to 5 percent by weight based on the weight of the total composition are used. In addition to the The esters according to the invention, in particular menthyl lactate, have an enhancing effect, i.e. a taste-enhancing effect Effect on other flavors. For example, the addition of a also allows below the threshold value for a physiological cooling effect lying amount of the invention to be used esters such as chewing gum or Amount of peppermint oil incorporated into dentists as flavorings, Spearmint oil, or other flavorings, without degrading that there is a deviation in taste.
Die folgenden Beispiele erläutern die Anwendung der erfindungsgemäßen Kühlmittel in verschiedenen Zusammensetzungen.Bei den Prozentangaben handelt es sich, sofern nichts anderes angegeben 1st um Gewichtsprozent.The following examples explain the use of the coolants according to the invention in various compositions. Unless otherwise stated, the percentages are percentages by weight.
HR 62 - 4 -HR 62 - 4 -
709836/0088709836/0088
Beispiel 1
Zahnpasta example 1
toothpaste
Folgende Komponenten wurden in üblicher Weise vermischt:The following components were mixed in the usual way:
Glycerin DAB 6 20 %Glycerin DAB 6 20%
p-Hydroxybenzoesäuremethylester 0,15 % p-hydroxybenzoic acid methyl ester 0.15 %
Carboxymethylcellulose 1,2 % Carboxymethyl cellulose 1.2 %
Saccharin 0,2 % Saccharin 0.2 %
Dicalciumphosphat (wasserhaltig) 48 % Dicalcium phosphate (containing water) 48 %
Natriumlaurylsulfat 2,2 % Sodium Lauryl Sulphate 2.2 %
Geschmackstoffe 1,0 % Flavors 1.0 %
Wasser 100 % Water 100 %
Vor Beendigung des Mischvorgangs wurde 1 % 1-Menthyllactat zugesetzt. Die Zahnpasta zeichnet sich durch eine Kühlwirkung aus.Before the end of the mixing process, 1 % 1-menthyl lactate was added. The toothpaste is characterized by a cooling effect.
Beispiel 2
Kaugummi Example 2
chewing gum
In eine handelsübliche Kaugummibase wurden 0,3 % O-Acetylmilchsäure-1-menthylester eingearbeitet. Die Kaugummimasse erzeugt im Munde ein Kühlegefühl.In a commercially available gum base 0.3% O-Acetylmilchsäure-1-menthyl ester were incorporated. The chewing gum mass creates a feeling of coolness in the mouth.
Beispiel 3Example 3
Fondantfondant
1 % 1-Menthyllactat wurde in eine handelsübliche Fondantgrundbase eingearbeitet. Die Fondantmasse weist einen angenehm erfrischenden Geschmack auf.1 % 1-menthyl lactate was incorporated into a commercially available fondant base. The fondant mass has a pleasantly refreshing taste.
HR 62 - 5 -HR 62 - 5 -
709836/0088709836/0088
Beispiel 4
Mundwasser Example 4
Mouthwash
Ein Mundwasserkonzentrat wurde aus folgenden Bestandteilen hergestellt:A mouthwash concentrate was made from the following ingredients:
Aethanol 60 % Ethanol 60 %
Bromchlorophen 0,05 % Bromochlorophene 0.05 %
Polyoxyäthylen-Sorbitan-monolaureat 1 % Polyoxyethylene sorbitan monolaureate 1 %
Allantoin 0,2 % Allantoin 0.2 %
Saccharin 0,2 %Saccharin 0.2%
Geschmackstoffe auf 100 % Flavors to 100 %
Der Mischung wurden 5 % 1-Menthyllactat zugesetzt. Für die Herstellung von Mundwasser wurde das Konzentrat mit dem 10-fachen seines Volumens an Wasser verdünnt. Das Mundwasser zeichnet sich durch eine Kühlwirkung aus.5 % 1-menthyl lactate was added to the mixture. For the preparation of mouthwash, the concentrate was diluted with 10 times its volume of water. The mouthwash is characterized by a cooling effect.
Ein gleichartig wirkendes Mundwasser wurde erhalten, wenn anstelle der 5 % 1-Menthyllactat die gleiche Menge Glycolsäure-, ß-Hydroxybuttersäure-, <X< -Hydroxyisovaleriansäure-, A -Hydroxy-ct- methylvaleriansäure-, o& -Hydroxy-^-methylvaleriansäure-, flt-Hydroxycapronsäure- oder ß-Hydroxycapronsäure-1-menthylester eingesetzt wurde. A similarly acting mouthwash was obtained if, instead of the 5 % 1-menthyl lactate, the same amount of glycolic acid, ß-hydroxybutyric acid, <X < -hydroxyisovaleric acid, A -hydroxy-ct- methylvaleric acid-, o & -hydroxy- ^ - methylvaleric acid- , flt-hydroxycaproic acid or ß-hydroxycaproic acid 1-menthyl ester was used.
Ge s ichtsre inigungslotion Face cleansing lotion
Eine Gesichtsreinigungslotion wurde aus folgenden Komponenten hergestellt: A facial cleansing lotion was made from the following components:
HR 62 - 6 -HR 62 - 6 -
709836/0088709836/0088
Die Lotion ruft auf der Gesichtshaut eine Kühlwirkung hervor.The lotion has a cooling effect on the skin of the face.
Beispiel 6
After-Shave-Lotion Example 6
After shave lotion
Eine After-Shave-Lotion wurde aus folgenden Komponenten hergestellt: An after-shave lotion was made from the following components:
Aethanol 55,5 % Ethanol 55.5 %
1-Menthyllactat 1,5 % 1-menthyl lactate 1.5 %
Parfümöl 0,5 % Perfume oil 0.5 %
Emulgator 0,3 %Emulsifier 0.3%
Wasser 39,8 % Water 39.8 %
Allantoin 0,2 % Allantoin 0.2 %
1,2-Propylenglykol 2 % 1,2-propylene glycol 2 %
Milchsäure 0,2 %Lactic acid 0.2%
Die Lotion ruft bei der Auftragung auf das Gesicht eine Kühlwirkung hervor.The lotion produces a cooling effect when applied to the face.
Ein gleichartig wirkendes Präparat wurde erhalten;wenn anstelle von 1-Menthyllactat die gleiche Menge 0-Formylmilchsäure-1-menthylester eingesetzt wurde.A similarly acting preparation was obtained; if instead of 1-menthyl lactate the same amount of 0-formyllactic acid 1-menthyl ester was used.
HR 62 - 7 -HR 62 - 7 -
709836/0088709836/0088
Beispiel 7
Klarshampoo Example 7
Clear shampoo
Ein Klarshampoo wurde aus folgenden Komponenten hergestellt:A clear shampoo is made from the following components:
Fettsäureamidoalkylbetain 60 % Fatty acid amidoalkyl betaine 60 %
Wasser 35,2 % Water 35.2 %
Konservierungsmittel 0,2 % Preservative 0.2 %
d,1-Menthyllactat 2 % d, 1-menthyl lactate 2 %
Parfümöl 0,5 %Perfume oil 0.5%
Kokosfettsäurediäthanolamid 2 % Coconut fatty acid diethanolamide 2 %
Das Shampoo erzeugt auf der Kopfhaut eine starke Kühlwirkung.The shampoo creates a strong cooling effect on the scalp.
Beispiel 8
After-Bath-Freshener Example 8
After bath freshener
Ein After-Bath-Freshener wurde aus folgenden Bestandteilen hergestellt:An after-bath freshener was made from the following components:
Der After-Bath-Freshener zeichnet sich durch eine angenehm erfrischende Wirkung aus.The after-bath freshener is characterized by a pleasantly refreshing effect.
HR 62 - 8 -HR 62 - 8 -
709836/0088709836/0088
Claims (6)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762608226 DE2608226A1 (en) | 1976-02-28 | 1976-02-28 | AGENTS WITH PHYSIOLOGICAL COOLING EFFECT |
JP1876477A JPS52105223A (en) | 1976-02-28 | 1977-02-24 | Material having physiological cooling action and its utilization |
NL7702074A NL7702074A (en) | 1976-02-28 | 1977-02-25 | AGENT AND PREPARATION WITH A PHYSIOLOGICAL COOLING EFFECT ON THE SKIN AND MUSCLES OF THE BODY. |
FR7705787A FR2342057A1 (en) | 1976-02-28 | 1977-02-28 | Compsns. having physiological cooling activity - contg. menthol esters of natural hydroxycarboxylic acids opt. esterified at hydroxyl gp. (NL 3.8.77) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19762608226 DE2608226A1 (en) | 1976-02-28 | 1976-02-28 | AGENTS WITH PHYSIOLOGICAL COOLING EFFECT |
Publications (1)
Publication Number | Publication Date |
---|---|
DE2608226A1 true DE2608226A1 (en) | 1977-09-08 |
Family
ID=5971145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE19762608226 Pending DE2608226A1 (en) | 1976-02-28 | 1976-02-28 | AGENTS WITH PHYSIOLOGICAL COOLING EFFECT |
Country Status (4)
Country | Link |
---|---|
JP (1) | JPS52105223A (en) |
DE (1) | DE2608226A1 (en) |
FR (1) | FR2342057A1 (en) |
NL (1) | NL7702074A (en) |
Cited By (85)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5266592A (en) * | 1991-04-05 | 1993-11-30 | Haarmann & Reimer Gmbh | Compositions which have a physiological cooling effect, and active compounds suitable for these compositions |
WO1996014840A1 (en) * | 1994-11-14 | 1996-05-23 | Zyma S.A. | Use of menthyl lactate as a pain reliever |
WO1997002116A1 (en) * | 1995-06-30 | 1997-01-23 | The Gillette Company | Shaving aid composite with a non-volatile cooling agent |
WO1997007771A1 (en) * | 1995-08-29 | 1997-03-06 | V. Mane Fils S.A. | Refreshing compositions |
WO1997042945A1 (en) * | 1996-05-13 | 1997-11-20 | Novartis Consumer Health S.A. | Oral pharmaceutical compositions |
WO1997042944A1 (en) * | 1996-05-13 | 1997-11-20 | Novartis Consumer Health S.A. | Topical composition |
WO1998002182A1 (en) * | 1996-07-12 | 1998-01-22 | Novartis Consumer Health S.A. | Oral pharmaceutical combinations of nsaids with terpenoids |
US5725865A (en) * | 1995-08-29 | 1998-03-10 | V. Mane Fils S.A. | Coolant compositions |
US5752529A (en) * | 1996-08-21 | 1998-05-19 | V. Mane Fils S.A. | Tobacco products containing coolant compositions |
US5783725A (en) * | 1996-02-27 | 1998-07-21 | Haarmann & Reimer Gmbh | Stabilized lactic acid menthyl ester |
US5843466A (en) * | 1995-08-29 | 1998-12-01 | V. Mane Fils S.A. | Coolant compositions |
US5977166A (en) * | 1990-11-06 | 1999-11-02 | Wm. Wrigley Jr. Company | Enhanced flavors using menthone ketals |
US6214788B1 (en) | 1999-03-31 | 2001-04-10 | Firmenich Sa | Use of cubebol as a flavoring ingredient |
US6277385B1 (en) | 1992-06-17 | 2001-08-21 | The Procter & Gamble Company | Cooling compositions with reduced stinging |
US6359168B1 (en) | 1997-11-27 | 2002-03-19 | Firmenich Sa | Compounds derived from menthol and use as refreshing agent |
WO2002032388A3 (en) * | 2000-10-16 | 2002-08-22 | Colgate Palmolive Co | Oral compositions for reducing mouth odors |
US6455080B1 (en) | 1997-12-29 | 2002-09-24 | Wm. Wrigley Jr., Company | Chewing gum containing controlled release acyclic carboxamide and method of making |
EP1250941A1 (en) * | 2001-04-17 | 2002-10-23 | The Procter & Gamble Company | Articles comprising a mint odor-free cooling agent |
EP1250940A1 (en) * | 2001-04-17 | 2002-10-23 | The Procter & Gamble Company | An absorbent article comprising an agent able to convey a perception to the wearer |
US6627233B1 (en) | 1997-09-18 | 2003-09-30 | Wm. Wrigley Jr. Company | Chewing gum containing physiological cooling agents |
US7025997B2 (en) | 2003-09-24 | 2006-04-11 | International Flavors & Fragrances Inc. | Coolant plant extract compositions containing monomenthyl succinate |
EP1716837A1 (en) | 2005-02-28 | 2006-11-02 | The Procter & Gamble Company | Use of a volatile cooling sensate on fibrous tissues to provide a sensation of rhinological decongestion |
EP1935252A1 (en) | 1997-09-18 | 2008-06-25 | WM. Wrigley Jr., Company | Chewing gum composition |
EP2033688A2 (en) | 2007-08-20 | 2009-03-11 | Symrise GmbH & Co. KG | Oxalic acid derivatives and their use as physiological cooling agents |
US7803963B2 (en) | 2007-10-15 | 2010-09-28 | Millennium Specialty Chemicals, Inc. | Physiological coolants based on lactoyl esters of menthyl lactate |
WO2010149798A3 (en) * | 2010-06-14 | 2011-04-14 | Symrise Ag | Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect |
WO2011061330A2 (en) | 2009-11-20 | 2011-05-26 | Symrise Ag | Use of physiological cooling active ingredients, and agents containing such active ingredients |
EP2478777A1 (en) | 2005-12-23 | 2012-07-25 | Kraft Foods Global Brands LLC | Composition providing a cooling sensation substantially similar to that provided by menthol |
US8273367B2 (en) | 2001-04-17 | 2012-09-25 | The Procter And Gamble Company | Articles comprising a mint odor-free cooling agent |
US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
EP2559424A1 (en) | 2005-10-05 | 2013-02-20 | Kraft Foods Global Brands LLC | Cooling composition comprising trimethyl isopropyl butanamide |
WO2013041621A1 (en) | 2011-09-20 | 2013-03-28 | Basf Se | Low molecular weight modulators of the cold-menthol receptor trpm8 and use thereof |
US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
EP2620137A1 (en) | 2012-01-30 | 2013-07-31 | Symrise AG | Compositions |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
WO2013171018A2 (en) | 2012-05-16 | 2013-11-21 | Symrise Ag | Mixtures having improved cooling effect |
US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US8709385B2 (en) | 2008-01-14 | 2014-04-29 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
WO2014090293A1 (en) | 2012-12-12 | 2014-06-19 | Symrise Ag | Preparations |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
EP2801263A1 (en) | 2013-05-09 | 2014-11-12 | Symrise AG | Cooling composition |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
EP2423290A4 (en) * | 2009-04-24 | 2015-05-27 | Takasago Perfumery Co Ltd | Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
EP1250914B2 (en) † | 2001-04-17 | 2015-11-25 | The Procter & Gamble Company | Cooling compositions |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
EP2962679A1 (en) | 2014-06-30 | 2016-01-06 | Symrise AG | Use of tetrahydrofuranlignans |
EP2979751A1 (en) | 2014-07-29 | 2016-02-03 | Symrise AG | Process for the manufacturing of solid cooling agents |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
DE202012013357U1 (en) | 2012-12-12 | 2016-07-29 | Symrise Ag | preparations |
EP3059009A1 (en) | 2015-02-19 | 2016-08-24 | Symrise AG | Process for the storage of refreshing agents |
WO2016139066A1 (en) | 2015-03-04 | 2016-09-09 | Symrise Ag | Compositions comprising menthol compounds as soothing agents |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
WO2017190789A1 (en) | 2016-05-05 | 2017-11-09 | Symrise Ag | Coolant mixtures |
WO2017198284A1 (en) | 2016-05-14 | 2017-11-23 | Symrise Ag | Menthol-containing aroma preparations |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
WO2019043164A1 (en) | 2017-08-31 | 2019-03-07 | Basf Se | Use of physiological cooling active ingredients, and compositions comprising such active ingredients |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US10722434B2 (en) * | 2015-05-15 | 2020-07-28 | Symrise Ag | Liquid cooling compositions |
EP3689324A1 (en) | 2019-02-04 | 2020-08-05 | Symrise AG | New cooling agents and preparations comprising them |
WO2022105986A1 (en) | 2020-11-17 | 2022-05-27 | Symrise Ag | Novel cooling agents and preparations containing same |
WO2022122144A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | A method for fighting microorganisms using menthol derivatives |
WO2022207944A2 (en) | 2022-07-11 | 2022-10-06 | Symrise Ag | Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide |
WO2022258189A1 (en) | 2021-06-10 | 2022-12-15 | Symrise Ag | Compositions for fighting malodors |
WO2023021012A1 (en) | 2021-08-16 | 2023-02-23 | Symrise Ag | Compositions |
WO2023083445A1 (en) | 2021-11-10 | 2023-05-19 | Symrise Ag | Compositions comprising trpm8 agonistic cooling agents |
WO2023131667A1 (en) | 2022-01-07 | 2023-07-13 | V. Mane Fils | Cooling compounds and compositions |
WO2023143741A1 (en) | 2022-01-28 | 2023-08-03 | Symrise Ag | New coolants, and preparations containing same |
WO2023147852A1 (en) | 2022-02-02 | 2023-08-10 | Symrise Ag | Compositions (iii) |
WO2023222577A1 (en) | 2022-05-18 | 2023-11-23 | Symrise Ag | Antimicrobial mixtures |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63170123A (en) * | 1986-12-29 | 1988-07-14 | Nippon Denso Co Ltd | Air conditioning device |
JPH01149710A (en) * | 1987-12-07 | 1989-06-12 | Sunstar Inc | Detergent composition |
FR2788695B1 (en) * | 1999-01-22 | 2002-09-06 | Roc Sa | COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, SMALL ODORANT AND NON-IRRITANT |
CN107532063B (en) | 2015-03-25 | 2020-03-10 | 高砂香料工业株式会社 | Methylmenthol derivative and cold-sensitive composition containing the same |
-
1976
- 1976-02-28 DE DE19762608226 patent/DE2608226A1/en active Pending
-
1977
- 1977-02-24 JP JP1876477A patent/JPS52105223A/en active Pending
- 1977-02-25 NL NL7702074A patent/NL7702074A/en not_active Application Discontinuation
- 1977-02-28 FR FR7705787A patent/FR2342057A1/en not_active Withdrawn
Cited By (152)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977166A (en) * | 1990-11-06 | 1999-11-02 | Wm. Wrigley Jr. Company | Enhanced flavors using menthone ketals |
US5266592A (en) * | 1991-04-05 | 1993-11-30 | Haarmann & Reimer Gmbh | Compositions which have a physiological cooling effect, and active compounds suitable for these compositions |
US6277385B1 (en) | 1992-06-17 | 2001-08-21 | The Procter & Gamble Company | Cooling compositions with reduced stinging |
WO1996014840A1 (en) * | 1994-11-14 | 1996-05-23 | Zyma S.A. | Use of menthyl lactate as a pain reliever |
WO1997002116A1 (en) * | 1995-06-30 | 1997-01-23 | The Gillette Company | Shaving aid composite with a non-volatile cooling agent |
WO1997007771A1 (en) * | 1995-08-29 | 1997-03-06 | V. Mane Fils S.A. | Refreshing compositions |
US5843466A (en) * | 1995-08-29 | 1998-12-01 | V. Mane Fils S.A. | Coolant compositions |
US5725865A (en) * | 1995-08-29 | 1998-03-10 | V. Mane Fils S.A. | Coolant compositions |
US5783725A (en) * | 1996-02-27 | 1998-07-21 | Haarmann & Reimer Gmbh | Stabilized lactic acid menthyl ester |
WO1997042944A1 (en) * | 1996-05-13 | 1997-11-20 | Novartis Consumer Health S.A. | Topical composition |
WO1997042945A1 (en) * | 1996-05-13 | 1997-11-20 | Novartis Consumer Health S.A. | Oral pharmaceutical compositions |
WO1998002182A1 (en) * | 1996-07-12 | 1998-01-22 | Novartis Consumer Health S.A. | Oral pharmaceutical combinations of nsaids with terpenoids |
US5752529A (en) * | 1996-08-21 | 1998-05-19 | V. Mane Fils S.A. | Tobacco products containing coolant compositions |
US6627233B1 (en) | 1997-09-18 | 2003-09-30 | Wm. Wrigley Jr. Company | Chewing gum containing physiological cooling agents |
EP1935252A1 (en) | 1997-09-18 | 2008-06-25 | WM. Wrigley Jr., Company | Chewing gum composition |
US6359168B1 (en) | 1997-11-27 | 2002-03-19 | Firmenich Sa | Compounds derived from menthol and use as refreshing agent |
US6455080B1 (en) | 1997-12-29 | 2002-09-24 | Wm. Wrigley Jr., Company | Chewing gum containing controlled release acyclic carboxamide and method of making |
US6214788B1 (en) | 1999-03-31 | 2001-04-10 | Firmenich Sa | Use of cubebol as a flavoring ingredient |
US8512718B2 (en) | 2000-07-03 | 2013-08-20 | Foamix Ltd. | Pharmaceutical composition for topical application |
WO2002032388A3 (en) * | 2000-10-16 | 2002-08-22 | Colgate Palmolive Co | Oral compositions for reducing mouth odors |
EP1250941A1 (en) * | 2001-04-17 | 2002-10-23 | The Procter & Gamble Company | Articles comprising a mint odor-free cooling agent |
US8273367B2 (en) | 2001-04-17 | 2012-09-25 | The Procter And Gamble Company | Articles comprising a mint odor-free cooling agent |
EP1250914B2 (en) † | 2001-04-17 | 2015-11-25 | The Procter & Gamble Company | Cooling compositions |
WO2002083192A1 (en) * | 2001-04-17 | 2002-10-24 | The Procter & Gamble Company | Articles comprising a mint odor-free cooling agent |
WO2002083191A1 (en) * | 2001-04-17 | 2002-10-24 | The Procter & Gamble Company | An absorbent article comprising an agent able to convey a perception to the wearer |
EP1250940A1 (en) * | 2001-04-17 | 2002-10-23 | The Procter & Gamble Company | An absorbent article comprising an agent able to convey a perception to the wearer |
CN100540063C (en) * | 2001-04-17 | 2009-09-16 | 宝洁公司 | The goods that comprise the cool agent that does not contain mint smell |
CN1501816B (en) * | 2001-04-17 | 2010-05-26 | 宝洁公司 | An absorbent article comprising an agent able to convey a perception to the wearer |
US8435498B2 (en) | 2002-10-25 | 2013-05-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
US9492412B2 (en) | 2002-10-25 | 2016-11-15 | Foamix Pharmaceuticals Ltd. | Penetrating pharmaceutical foam |
US11033491B2 (en) | 2002-10-25 | 2021-06-15 | Vyne Therapeutics Inc. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9539208B2 (en) | 2002-10-25 | 2017-01-10 | Foamix Pharmaceuticals Ltd. | Foam prepared from nanoemulsions and uses |
US9622947B2 (en) | 2002-10-25 | 2017-04-18 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US9320705B2 (en) | 2002-10-25 | 2016-04-26 | Foamix Pharmaceuticals Ltd. | Sensation modifying topical composition foam |
US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8741265B2 (en) | 2002-10-25 | 2014-06-03 | Foamix Ltd. | Penetrating pharmaceutical foam |
US8722021B2 (en) | 2002-10-25 | 2014-05-13 | Foamix Ltd. | Foamable carriers |
US9713643B2 (en) | 2002-10-25 | 2017-07-25 | Foamix Pharmaceuticals Ltd. | Foamable carriers |
US10821077B2 (en) | 2002-10-25 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US8900554B2 (en) | 2002-10-25 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Foamable composition and uses thereof |
US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
US8840869B2 (en) | 2002-10-25 | 2014-09-23 | Foamix Ltd. | Body cavity foams |
US8486376B2 (en) | 2002-10-25 | 2013-07-16 | Foamix Ltd. | Moisturizing foam containing lanolin |
US10322085B2 (en) | 2002-10-25 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
US8486375B2 (en) | 2003-04-28 | 2013-07-16 | Foamix Ltd. | Foamable compositions |
US8795693B2 (en) | 2003-08-04 | 2014-08-05 | Foamix Ltd. | Compositions with modulating agents |
US9050253B2 (en) | 2003-08-04 | 2015-06-09 | Foamix Pharmaceuticals Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8362091B2 (en) | 2003-08-04 | 2013-01-29 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US8703105B2 (en) | 2003-08-04 | 2014-04-22 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8518378B2 (en) | 2003-08-04 | 2013-08-27 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
US8486374B2 (en) | 2003-08-04 | 2013-07-16 | Foamix Ltd. | Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses |
US9636405B2 (en) | 2003-08-04 | 2017-05-02 | Foamix Pharmaceuticals Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
US9101662B2 (en) | 2003-08-04 | 2015-08-11 | Foamix Pharmaceuticals Ltd. | Compositions with modulating agents |
US7025997B2 (en) | 2003-09-24 | 2006-04-11 | International Flavors & Fragrances Inc. | Coolant plant extract compositions containing monomenthyl succinate |
EP1716837A1 (en) | 2005-02-28 | 2006-11-02 | The Procter & Gamble Company | Use of a volatile cooling sensate on fibrous tissues to provide a sensation of rhinological decongestion |
EP2559424A1 (en) | 2005-10-05 | 2013-02-20 | Kraft Foods Global Brands LLC | Cooling composition comprising trimethyl isopropyl butanamide |
EP2478777A1 (en) | 2005-12-23 | 2012-07-25 | Kraft Foods Global Brands LLC | Composition providing a cooling sensation substantially similar to that provided by menthol |
US9682021B2 (en) | 2006-11-14 | 2017-06-20 | Foamix Pharmaceuticals Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US8795635B2 (en) | 2006-11-14 | 2014-08-05 | Foamix Ltd. | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
US10369102B2 (en) | 2007-08-07 | 2019-08-06 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US9662298B2 (en) | 2007-08-07 | 2017-05-30 | Foamix Pharmaceuticals Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
US11103454B2 (en) | 2007-08-07 | 2021-08-31 | Vyne Therapeutics Inc. | Wax foamable vehicle and pharmaceutical compositions thereof |
EP2033688A2 (en) | 2007-08-20 | 2009-03-11 | Symrise GmbH & Co. KG | Oxalic acid derivatives and their use as physiological cooling agents |
US8344025B2 (en) | 2007-08-20 | 2013-01-01 | Symrise Ag | Oxalic acid derivatives and use thereof as physiological cooling active ingredients |
US7803963B2 (en) | 2007-10-15 | 2010-09-28 | Millennium Specialty Chemicals, Inc. | Physiological coolants based on lactoyl esters of menthyl lactate |
US7968744B2 (en) | 2007-10-15 | 2011-06-28 | Renessenz, Llc | Physiological coolants based on lactoyl esters of menthyl lactate |
US9439857B2 (en) | 2007-11-30 | 2016-09-13 | Foamix Pharmaceuticals Ltd. | Foam containing benzoyl peroxide |
US11433025B2 (en) | 2007-12-07 | 2022-09-06 | Vyne Therapeutics Inc. | Oil foamable carriers and formulations |
US9161916B2 (en) | 2007-12-07 | 2015-10-20 | Foamix Pharmaceuticals Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US9795564B2 (en) | 2007-12-07 | 2017-10-24 | Foamix Pharmaceuticals Ltd. | Oil-based foamable carriers and formulations |
US8900553B2 (en) | 2007-12-07 | 2014-12-02 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US8343945B2 (en) | 2007-12-07 | 2013-01-01 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
US8518376B2 (en) | 2007-12-07 | 2013-08-27 | Foamix Ltd. | Oil-based foamable carriers and formulations |
US9549898B2 (en) | 2007-12-07 | 2017-01-24 | Foamix Pharmaceuticals Ltd. | Oil and liquid silicone foamable carriers and formulations |
US8709385B2 (en) | 2008-01-14 | 2014-04-29 | Foamix Ltd. | Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses |
EP2423290A4 (en) * | 2009-04-24 | 2015-05-27 | Takasago Perfumery Co Ltd | Process for producing 1-menthyl (3s)-3-hydroxybutanoate and composition for stimulating sense |
US9884017B2 (en) | 2009-04-28 | 2018-02-06 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10213384B2 (en) | 2009-04-28 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10588858B2 (en) | 2009-04-28 | 2020-03-17 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10363216B2 (en) | 2009-04-28 | 2019-07-30 | Foamix Pharmaceuticals Ltd. | Foamable vehicles and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
US10350166B2 (en) | 2009-07-29 | 2019-07-16 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US9167813B2 (en) | 2009-07-29 | 2015-10-27 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US11219631B2 (en) | 2009-07-29 | 2022-01-11 | Vyne Pharmaceuticals Inc. | Foamable compositions, breakable foams and their uses |
US10092588B2 (en) | 2009-07-29 | 2018-10-09 | Foamix Pharmaceuticals Ltd. | Foamable compositions, breakable foams and their uses |
US9572775B2 (en) | 2009-07-29 | 2017-02-21 | Foamix Pharmaceuticals Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
US9072667B2 (en) | 2009-07-29 | 2015-07-07 | Foamix Pharmaceuticals Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
US10517882B2 (en) | 2009-10-02 | 2019-12-31 | Foamix Pharmaceuticals Ltd. | Method for healing of an infected acne lesion without scarring |
US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
US10967063B2 (en) | 2009-10-02 | 2021-04-06 | Vyne Therapeutics Inc. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US9675700B2 (en) | 2009-10-02 | 2017-06-13 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10835613B2 (en) | 2009-10-02 | 2020-11-17 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8992896B2 (en) | 2009-10-02 | 2015-03-31 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10821187B2 (en) | 2009-10-02 | 2020-11-03 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US8865139B1 (en) | 2009-10-02 | 2014-10-21 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8945516B2 (en) | 2009-10-02 | 2015-02-03 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10265404B2 (en) | 2009-10-02 | 2019-04-23 | Foamix Pharmaceuticals Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
US10946101B2 (en) | 2009-10-02 | 2021-03-16 | Vyne Therapeutics Inc. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10322186B2 (en) | 2009-10-02 | 2019-06-18 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10238746B2 (en) | 2009-10-02 | 2019-03-26 | Foamix Pharmaceuticals Ltd | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10610599B2 (en) | 2009-10-02 | 2020-04-07 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10086080B2 (en) | 2009-10-02 | 2018-10-02 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
US10463742B2 (en) | 2009-10-02 | 2019-11-05 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US10137200B2 (en) | 2009-10-02 | 2018-11-27 | Foamix Pharmaceuticals Ltd. | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
US10213512B2 (en) | 2009-10-02 | 2019-02-26 | Foamix Pharmaceuticals Ltd. | Topical tetracycline compositions |
US8871184B2 (en) | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
US8618081B2 (en) | 2009-10-02 | 2013-12-31 | Foamix Ltd. | Compositions, gels and foams with rheology modulators and uses thereof |
EP3663366A2 (en) | 2009-11-20 | 2020-06-10 | Symrise AG | Use of physiological cooling ingredients and agents containing such active ingredients |
WO2011061330A2 (en) | 2009-11-20 | 2011-05-26 | Symrise Ag | Use of physiological cooling active ingredients, and agents containing such active ingredients |
DE102010002558A1 (en) | 2009-11-20 | 2011-06-01 | Symrise Ag | Use of physiological cooling agents and agents containing such agents |
US11491091B2 (en) | 2010-06-14 | 2022-11-08 | Symrise Ag | Cooling product |
WO2010149798A3 (en) * | 2010-06-14 | 2011-04-14 | Symrise Ag | Use of polyols for enhancing the cooling effect of a cooling substance and cooling mixtures having an enhanced cooling effect |
WO2013041621A1 (en) | 2011-09-20 | 2013-03-28 | Basf Se | Low molecular weight modulators of the cold-menthol receptor trpm8 and use thereof |
EP2620137A1 (en) | 2012-01-30 | 2013-07-31 | Symrise AG | Compositions |
EP3219303A1 (en) | 2012-01-30 | 2017-09-20 | Symrise AG | Compositions |
US9743685B2 (en) | 2012-05-16 | 2017-08-29 | Symrise Ag | Mixtures having improved cooling effect |
WO2013171018A2 (en) | 2012-05-16 | 2013-11-21 | Symrise Ag | Mixtures having improved cooling effect |
WO2014090293A1 (en) | 2012-12-12 | 2014-06-19 | Symrise Ag | Preparations |
DE202012013357U1 (en) | 2012-12-12 | 2016-07-29 | Symrise Ag | preparations |
EP2801263A1 (en) | 2013-05-09 | 2014-11-12 | Symrise AG | Cooling composition |
DE102014006596A1 (en) | 2013-05-09 | 2014-11-13 | Symrise Ag | Cooling composition |
EP2962679A1 (en) | 2014-06-30 | 2016-01-06 | Symrise AG | Use of tetrahydrofuranlignans |
EP2979751A1 (en) | 2014-07-29 | 2016-02-03 | Symrise AG | Process for the manufacturing of solid cooling agents |
EP4015075A1 (en) | 2015-02-19 | 2022-06-22 | Symrise AG | Standard packages with fixed cooling materials |
EP3059009A1 (en) | 2015-02-19 | 2016-08-24 | Symrise AG | Process for the storage of refreshing agents |
WO2016131710A1 (en) | 2015-02-19 | 2016-08-25 | Symrise Ag | Method for storing cooling agents |
WO2016139066A1 (en) | 2015-03-04 | 2016-09-09 | Symrise Ag | Compositions comprising menthol compounds as soothing agents |
US10722434B2 (en) * | 2015-05-15 | 2020-07-28 | Symrise Ag | Liquid cooling compositions |
WO2017190789A1 (en) | 2016-05-05 | 2017-11-09 | Symrise Ag | Coolant mixtures |
WO2017198284A1 (en) | 2016-05-14 | 2017-11-23 | Symrise Ag | Menthol-containing aroma preparations |
US11324691B2 (en) | 2016-09-08 | 2022-05-10 | Journey Medical Corporation | Compositions and methods for treating rosacea and acne |
US10849847B2 (en) | 2016-09-08 | 2020-12-01 | Foamix Pharamaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US10398641B2 (en) | 2016-09-08 | 2019-09-03 | Foamix Pharmaceuticals Ltd. | Compositions and methods for treating rosacea and acne |
US11434220B2 (en) | 2017-08-31 | 2022-09-06 | Basf Se | Use of physiological cooling active ingredients, and compositions comprising such active ingredients |
WO2019043164A1 (en) | 2017-08-31 | 2019-03-07 | Basf Se | Use of physiological cooling active ingredients, and compositions comprising such active ingredients |
EP3689324A1 (en) | 2019-02-04 | 2020-08-05 | Symrise AG | New cooling agents and preparations comprising them |
WO2022105986A1 (en) | 2020-11-17 | 2022-05-27 | Symrise Ag | Novel cooling agents and preparations containing same |
WO2022106452A2 (en) | 2020-11-17 | 2022-05-27 | Symrise Ag | New coolants, and preparations containing same |
WO2022122144A1 (en) | 2020-12-09 | 2022-06-16 | Symrise Ag | A method for fighting microorganisms using menthol derivatives |
WO2022258189A1 (en) | 2021-06-10 | 2022-12-15 | Symrise Ag | Compositions for fighting malodors |
WO2023021012A1 (en) | 2021-08-16 | 2023-02-23 | Symrise Ag | Compositions |
WO2023083445A1 (en) | 2021-11-10 | 2023-05-19 | Symrise Ag | Compositions comprising trpm8 agonistic cooling agents |
WO2023131667A1 (en) | 2022-01-07 | 2023-07-13 | V. Mane Fils | Cooling compounds and compositions |
WO2023143741A1 (en) | 2022-01-28 | 2023-08-03 | Symrise Ag | New coolants, and preparations containing same |
WO2023144326A1 (en) | 2022-01-28 | 2023-08-03 | Symrise Ag | New coolants, and preparations containing same |
WO2023147852A1 (en) | 2022-02-02 | 2023-08-10 | Symrise Ag | Compositions (iii) |
WO2023222577A1 (en) | 2022-05-18 | 2023-11-23 | Symrise Ag | Antimicrobial mixtures |
WO2023222213A1 (en) | 2022-05-18 | 2023-11-23 | Symrise Ag | Antimicrobial mixtures |
WO2022207944A2 (en) | 2022-07-11 | 2022-10-06 | Symrise Ag | Novel mixtures and uses of (2e)-3-(1,3-benzodioxol-5-yl)-n-phenyl-n-(tetrahydro-3-furanyl)-2-propenamide |
Also Published As
Publication number | Publication date |
---|---|
JPS52105223A (en) | 1977-09-03 |
FR2342057A1 (en) | 1977-09-23 |
NL7702074A (en) | 1977-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE2608226A1 (en) | AGENTS WITH PHYSIOLOGICAL COOLING EFFECT | |
DE2202535C3 (en) | Use of p-menthan derivatives | |
DE2205255C3 (en) | N-substituted p-menthane-3-carboxamides and agents containing them for stimulating the cold receptors of the nervous system | |
DE2516610C2 (en) | Consumable product with a physiological cooling effect | |
DE2433165C2 (en) | N-acetylglycine-1-menthyl ester, process for its preparation and dentifrices containing this ester | |
DE2366423C2 (en) | Use of carboxamides as cold receptor stimulants for objects or means with a cooling effect | |
US4034109A (en) | Compounds having a physiological cooling effect and compositions containing them | |
DE60126451T2 (en) | Method and means for improving the diffusion and persistence properties of a perfume | |
DE1917393A1 (en) | Perfumed and flavored products | |
DE69920567T2 (en) | Method of preventing the body odor of old people | |
US3644613A (en) | Oral. nasal and labial compositions containing menthyl keto esters | |
DE2624504A1 (en) | COMPOUND OR OBJECTIVE WITH A STIMULATING EFFECT TO THE COLD RECEPTORS OF THE HUMAN NERVOUS SYSTEM | |
DE1667871A1 (en) | Liquid dentifrices containing abrasives | |
DE60001918T2 (en) | COSMETIC COMPOSITION BASED ON MENTHOL AND MENTHYL LACTATE, WHICH HAS A LOW SMELL AND IS NOT IRRITANT | |
CA1041506A (en) | Compounds having a physiological cooling effect and compositions containing them | |
EP0306853B1 (en) | Cosmetic composition with germicidal properties | |
DE2439770A1 (en) | AGENTS WITH PHYSIOLOGICAL COOLING EFFECT | |
DE2317539C2 (en) | Cyclohexanecarboxamides and their use as agents for stimulating the cold receptors of the human nervous system | |
DE2458562C2 (en) | Consumable product with a compound that stimulates the cold receptors of the nervous system | |
US3793446A (en) | Oral,nasal and labial compositions containing menthyl keto esters | |
DE2317000A1 (en) | Means of stimulating the cold receptors of the human nervous system and their use | |
DE2316999A1 (en) | Means of stimulating the cold receptors of the human nervous system and their use | |
DE2456639A1 (en) | Sprayable ester contg deodorant compsn - prevents container corrosion without reducing bacteriostatic activity | |
DE2012328A1 (en) | ||
EP2026750B1 (en) | Denaturing agent for ethanol and its cosmetic or oral hygienic product |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OHN | Withdrawal |